Mechanically ventilated patients in the United States and Europe were randomized to oral topical iseganan or placebo ( 1:1 ) and treated six times per day while intubated for up to 14 d. Patients were eligible if randomized within 24 h of intubation and estimated to survive and remain mechanically ventilated for 48 h or more .
